Prescribing anti-rheumatic drugs in pregnancy and breastfeeding—the British Society for Rheumatology guideline scope

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

“…The rationale behind this update of the 2016 British Society for Rheumatology (BSR) guidelines on prescribing antirheumatic drugs in pregnancy and breastfeeding [1,2] was described in detail in the guideline scope [3]. In brief, despite the existence of additional evidence-based guidelines on prescribing/managing rheumatic disease in pregnancy [4][5][6][7], the information contained within them requires continual review to include emerging information on the safety of new and existing drugs in pregnancy.…”

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

“…The rationale behind this update of the 2016 British Society for Rheumatology (BSR) guidelines on prescribing antirheumatic drugs in pregnancy and breastfeeding [1,2] was previously described [3]. Additional evidence-based guidelines on managing rheumatic disease in pregnancy now exist [4][5][6][7].…”

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice

“…The rationale behind this update on the 2016 British Society for Rheumatology (BSR) guidelines on prescribing antirheumatic drugs in pregnancy and breastfeeding [1,2] was described in detail in the guideline scope [3]. In brief, despite the existence of additional evidence-based guidelines on prescribing/managing rheumatic disease in pregnancy [4][5][6][7] the information contained within them requires continual review to include emerging information on the safety of new and existing drugs in pregnancy.…”